Back to today’s briefing

Story perspectives

FDA Cuts Drug Approval Time to Just 1-2 Months!

6/21/2025

37 8

Left

Makary Accelerates Drug Approvals

The FDA, led by Commissioner Marty Makary, is revolutionizing drug approvals with a groundbreaking pilot program that slashes review times from 10-12 months to just 1-2 months. By enabling real-time data submission during trials, this initiative not only boosts U.S. competitiveness and national security but also fosters innovation while upholding safety standards.

Center

Makary Reforming FDA Policies

The FDA has halted new clinical trials using U.S. patients' cells for genetic engineering in countries like China, raising concerns over consent and security. Under Commissioner Marty Makary, the agency is committed to reforming policies to rebuild public trust and safeguard America's position in biomedical innovation after a contentious exemption from the prior administration.

1 of 2

Makary Accelerates Drug Approvals

The FDA, led by Commissioner Marty Makary, is revolutionizing drug approvals with a groundbreaking pilot program that slashes review times from 10-12 months to just 1-2 months. By enabling real-time data submission during trials, this initiative not only boosts U.S. competitiveness and national security but also fosters innovation while upholding safety standards.

1 / 2